HIGHLIGHTS
- who: Fanny Leenhardt et al. from the Institut du Cancer de Montpellier, Universitu00e9 de Montpellier, rue des Apothicaires, Montpellier, France have published the Article: Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual Suspects, in the Journal: Pharmaceutics 2022, 14, 841. of 18/06/2018
- what: The pharmacokinetic-toxicity relationship and PK variability of palbociclib were characterized in real-life metastatic breast cancer patients (n=62).
SUMMARY
Neutropenia is one of the most frequently reported toxicities when using oncologic drugs. Of 12 Although . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.